Jacksonville, FL3 Active Studies

Neuroendocrine Tumors Clinical Trials in Jacksonville, FL

Find 3 actively recruiting neuroendocrine tumors clinical trials in Jacksonville, FL. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
648
Enrolling

Recruiting Neuroendocrine Tumors Studies in Jacksonville

About Neuroendocrine Tumors Clinical Trials in Jacksonville

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 3 neuroendocrine tumors clinical trials recruiting participants in Jacksonville, FL. These studies are seeking a combined 648 participants. Research is being sponsored by RayzeBio, Inc., Perspective Therapeutics, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Jacksonville — FAQ

Are there neuroendocrine tumors clinical trials in Jacksonville?

Yes, there are 3 neuroendocrine tumors clinical trials currently recruiting in Jacksonville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 3 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated March 2, 2026 from ClinicalTrials.gov